Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma Recruiting

2024-516078-31-00 Recurrent and Primary Refractory Ewing Sarcoma 10 2015-05-05
A Phase I/II trial of MK-3475 (pembrolizumab) in children's solid tumors and lymphoma Recruiting

2022-501257-36-00 Treatment of advanced melanoma, or advanced, relapsed o 9 2015-03-19
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication: BIOMEDE 2.0 Recruiting

2023-506027-29-00 Children, adolescents and adults with newly diagnosed d 5 2014-10-01
A Phase 1 study to test for safety and activity of an oral investigational drug, in patients with AML or other blood or bone marrow malignac… Recruiting

2024-511344-11-00 AG-120 is being investigated for the treatment of patie 1 2014-07-18
Evaluation of the effectiveness of genome analysis as a therapeutic decision tool for patients with metastatic breast cancer. Recruiting

2024-518002-41-00 Patients with metastatic breast cancer in 1st or 2nd li 4 2014-04-07
MOST Plus (My Own Specific Treatment) - A two-period, multicenter, randomized, open-label, phase II study evaluating the clinical benefit of… Recruiting

2023-510566-27-00 Advanced / Metastatic cancers 4 2014-02-27
MEMMAT - Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial Recruiting

2024-515626-92-00 recurrent/progressive medulloblastoma, ependymoma and a 4 2013-10-18
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects with Unresectable Malignant Mesothelioma Recruiting

2024-511841-20-00 unresectable pleural or peritoneal malignant mesothelio 4 2013-09-23
NOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years Recruiting

2024-518254-16-00 Acute Myeloid Leukemia (Pediatric 0-18 years) 5 2013-03-01
VshoRT-R3: Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperatIve treatment in low-moderate risk r… Recruiting

2024-513920-40-00 low- risk rectal cancel 9 2013-01-11
An Extension Study of trastuzumab emtansine administered as a single agent or in combination with other anti-cancer therapies in patients pr… Recruiting

2023-503479-79-00 Metastatic Cancer 4 2011-06-17
Hyperthermic Intraperitoneal Chemotherapy in the treatment of Ovarian Cancer relapse Recruiting

2024-517390-24-00 Ovarian epithelial cancer : intraperitoneal resectable 5 2011-04-26
PEHRICCA : PErioperative CISGEM plus RILVEGOSTOMIG in High-Risk resectable Intrahepatic CholangioCarcinoma Ended

2025-521302-17-00 Hihg risk of cholangiocarcinoma intra hépatic resectabl 10 2026-05-26
A phase II trial of 177Lutetium-DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma LuDO-N Ended

2023-503684-42-00 Neuroblastoma 4 2026-02-20
Wilms’ tumor (WT1) antigen-targeted dendritic cell vaccination to prevent relapse in adult patients with acute myeloid leukemia: a multicent… Ended

2024-515292-35-00 Acute Myeloid Leukemia 4 2026-01-09
A study of BMS-986504 in combination with Nab-p/Gem versus placebo in combination with Nab-p/Gem in untreated metastatic PDAC with homozygou… Ended

2025-522598-12-00 Untreated Metastatic Pancreatic Ductal Adenocarcinoma 10 2025-12-17
A Phase 1/2a Study of UCART22 in B-cell Acute Lymphoblastic Leukemia (BALLI-01) Ended

2022-502305-15-00 Relapsed or refractory B-cell Acute Lymphoblastic Leuk 7 2025-11-26
Phase 2b Clinical Study Evaluating Efficacy and Safety of TAR-200 in Combination with Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Part… Ended

2023-506146-23-00 Non-Muscle-Invasive Urothelial Carcinoma (NMIBC) of the 4 2025-11-17
MK-2870 versus Chemotherapy in Previously Treated or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) with EGFR Mutations or Other … Ended

2023-503539-16-00 Non-small Cell Lung Cancer (NSCLC) 5 2025-11-11
A Study of Subcutaneous Nivolumab plus Intravenous Ipilimumab and Chemotherapy in Participants with Previously Untreated Metastatic or Recur… Ended

2024-520108-25-00 Non-small cell lung cancer (NSCLC) 4 2025-11-05
A study of S095035 as a single agent and in combination in adult participants with advanced or metastatic solid tumors with deletion of MTAP Ended

2025-521249-25-00 MTAP-deleted advanced or metastatic solid tumors 7 2025-10-30
Master protocol of novel agents or combinations as perioperative treatment in participants with locally advanced resectable gastroesophagea… Ended

2024-516909-23-00 Locally Advanced Resectable Gastroesophageal Adenocarci 4 2025-10-28
A Phase II, randomized, open-label, multi-center study of JSB462 (luxdegalutamide) in combination with lutetium (177Lu) vipivotide tetraxeta… Ended

2024-520155-24-00 Metastatic castration resistant prostate cancer (mCRPC) 4 2025-10-16
Ribociclib in combination with endocrine therapy in patients with “estrogen receptor-positive and HER2-negative” breast cancer with high ris… Ended

2023-508827-10-00 Patients with primary operable stage II, grade 2 or 3, 4 2025-10-13